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Fear memory persistence, central for the development and maintenance of anxiety disorders, is partially genetically controlled.
Recently, consolidation and reconsolidation processes have been reported to affect fear memory stability and integrity. This
study explored the impact of reconsolidation processes and genetic make-up on fear reacquisition by manipulating
reconsolidation, using extinction performed outside or inside a reconsolidation interval. Reacquisition measured by skin
conductance responses was stronger in individuals that extinguished outside (6h) than inside (10min) the reconsolidation
interval. However, the effect was predominantly present in val/val homozygotes of the functional val158met polymorphism of the
catechol O-methyltransferase (COMT) enzyme and in short-allele carriers of the serotonin-transporter length 5-HTTLPR
polymorphism.Theseresultsdemonstratethatreconsolidationofhumanfearmemory isinﬂuencedby dopamine and serotonin-
related genes.
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Introduction
The acquisition and extinction of fear memories are crucial for
the aetiology and symptomatology of anxiety disorders like
post-traumatic stress disorder.
1,2 Recently, it has been demon-
strated that consolidation and reconsolidation processes affect
stability and durability of fear memories. A memory is initially
labile and consolidate over time to a more stable form.
3 It is
hypothesized that when a fear memory is reactivated, it is again
transformed to a labile state, and the following stabilization is
termed reconsolidation. Moreover, it is argued that during
reconsolidation, memories can be updated to incorporate new
information. Previous studies conﬁrm that pharmacologically
disrupted reconsolidation processes affect behaviour both in
animals
4 and humans.
5–7 Most reconsolidation studies have
used fear conditioning, the process where a fear memory is
formed by repeated pairing of a neutral stimulus with an
aversive unconditioned stimulus (UCS), subsequently leading
to an aversive reaction to the neutral stimulus. Thus, the neutral
stimulus becomes a conditioned stimulus (CSþ). The condi-
tioned reactions to CSþ can be weakened or abolished with
extinction training, that is, by exposure to CSþ without UCS,
but generally return with the passage of time (spontaneous
recovery). Using extinction training during the reconsolidation
phase inrodents, it has been demonstrated that reconsolidation
of an activated fear memory can be inﬂuenced also non-




fear reactions in humans was weakened when a previously
reinforced stimulus was presented 10min, but not 6h before
extinction training, that is inside, but not outside, of the
reconsolidation interval.
In Schiller study,
9 subjects completed a fear-conditioning
procedure to experimentally induce a fear memory. Twenty-four
hours after the initial conditioning session, subject returned
and the fear memory was activated by a 2-min presentation
of the CSþ in the absence of UCS. One group received
extinction training 10min after the fear memory activation and
hence, early during the reconsolidation process. The other
group received extinction training 6h after the fear memory
activation, hence after completion of reconsolidation. Another
24h later, spontaneous recovery of fear was tested in a
second extinction session. The results showed that the group
given extinction training during the reconsolidation interval
(i.e., 10min after memory activation) exhibited less fear,
as reﬂected by skin conductance response (SCR), when
exposed to CSþ, than the group that received extinction
training 6h after the memory activation. The effect of the
manipulationlingeredevenafter1yearwhenthereturnoffear
was tested with reinstatement, a process where extinguished
responses reappear to CSþ after unpaired UCS presenta-
tions.
Anxiety disorders wax and wane: In post-traumatic stress
disorder, for example, cues associated with trauma may
repeatedly reactivate symptoms instigated by a single
traumatic event. In addition, the remission rate after treatment
is incomplete, because symptom reactivation occurs.
10
Hence, it is clinically motivated to study if reconsolidation
processes inﬂuence not only the subsequent expression, but
also the reacquisition of fear. In fear conditioning, reacquisi-
tion is a second session of fear conditioning performed to
investigate how earlier manipulations of the memory affects a
relapse into renewed fear expression for the conditioned
stimulus.
Fear conditionability is a heritable characteristic
11 inﬂu-
enced by individual differences in serotonin- and dopamine-
related polymorphisms. In particular, short-allele (s) carriers
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(5–HTTLPR) display stronger acquisition and slower extinc-
tion compared with long-allele (ll) homozygotes.
12–14 More-
over, 5–HTTLPR has been associated with anxiety-related
personality traits,
15 development of psychopathology
16 and
enhanced reactivity of the amygdala,
17 a key structure for fear
conditioning,
18 suggesting a possible link between fear
memory processes, psychopathology and serotonergic
neurotransmission.





Catechhol-O-methyltransferase (COMT) is an enzyme vital to
the elimination of dopamine in prefrontal areas and the
functional polymorphism val158met (rs4680), where the val
allele is associated with higher COMT activity,
22 enables an
indirect way to study dopaminergic effects throughout the
brain.Twostudieshaverelatedfearconditioning totheCOMT
val158met genotype in humans, but with mixed ﬁndings.
Lonsdorf et al.
14 noted slower extinction in met homozygotes,
whereas Razcka et al.
23 noted stronger reacquisition in a val/
met-group, but only in the presence of a certain dopamine
transporter (DAT1) polymorphism.
As monoaminergic genetic polymorphisms modulate fear
conditioningandasreconsolidation inﬂuencefearexpression,
the present study investigated if serotonin- and dopamine-
related polymorphisms also affect reconsolidation. To
these aims, the present study utilized the non-pharmaco-
logical human reconsolidation disruption effect reported by
Schiller et al.
9 to study reacquisition of human fear indexed
by SCRs. The ap r i o r ihypotheses were that extinction
inside as compared to outside the reconsolidation interval
should compromise reacquisition and that monoaminergic
genes would modulate the effect. In addition, a previously
reported
5,9 reconsolidation effect for reinstatement was
predicted.
Materials and methods
Participants. A total of 66 participants (38 females, age:
mean±s.d.¼24.6±4.0) recruited by public advertisements
were randomly assigned to one of two groups. In one group,
extinction was given inside (10min), and in the other group,
outside (6h) the reconsolidation interval after a 2-min fear
memory reminder. Two subjects were excluded due to
technical difﬁculties. Subjects received SEK 400 for
participation.
Materials
Stimuli. Stimuli were projected on a 1700-computer screen
using E-prime 2.0. (Psychology Software Tools, Pittsburgh,
PA, USA) and consisted of a photo of a neutral environment
containing a lamp that was lit either in red or blue. One colour
was paired with UCS and became the CSþ, whereas the
other colour was unpaired (CS ). The CS colour was
counterbalanced across subjects. Each stimulus was
shown for 6s with 14-s intervals between trials when the
environment was displayed with the lamp unlit. A 500-ms
mild electric shock was delivered 250ms before the CSþ
ended.
Psychophysiology equipment. The electric shocks were
administered by PsychLabs SHK 1 pain stimulator (Psychlab,
Cambridge, MA, USA) and had a maximum strength of
5mA. Electrodes (EL124), prepared with electrolyte
medium to facilitate shock conduction were attached
with surgical tape to the dorsal right-lower arm of the
participants. The SCRs were measured in microsiemens
with the Psychlab 24-bit Skin Conductance System, using
two 8-mm Ag/AgCl electrodes ﬁlled with isotonic elec-
trolyte gel attached to the hypothenar eminence of the left
hand.
24
Genotyping. The 5-HTTLPR polymorphism in the promoter
of the serotonin transporter gene was ampliﬁed using the
PCR primers 50-ATGCCAGCACCTAACCCCTAATGT-30 and
50-GGACCGCAAGGTGGGCGGGA-30 yielding a product of
419bp for the 16-repeat allele (l) and 375bp for the 14-repeat
allele (s). After an initial denaturation step of 15min at 951C,
35 cycles were performed, including 30s at 951C, 30s at
661C ,a n da ne l o n g a t i o ns t e pa t7 2 1Cf o r1 m i n .
Genotyping was performed on 2% agarose gels. DNA
was visualized by ethidium bromide. Short-allele carriers
(n¼46) were grouped together and later compared with
homozygotes of the long allele (n¼16).
15,17 For two
subjects, the gene analysis failed to extract the 5-
HTTPLR genotype.
The val/met polymorphism in the gene encoding COMT
was analysed using the ABI 7900HT instrument with a
TaqMan assay in accordance with the protocol from the
manufacturer (Applied Biosystems, Foster City, CA, USA).
Given the functionality of the polymorphism,
25 homozygotes
of the val allele (n¼15) were grouped together and later
compared with carriers of the met allele (n¼46). Gene
analysis failed for three of the subjects.
Procedure
Day 1. Participants signed informed consent and determined
the strength of the unconditioned electric shock by following
the instruction that it should be unpleasant, but endurable.
They then underwent an acquisition session in which 16
CSþ and 16 CS  were presented in a random order, with
the limitation that no stimulus type was repeated more than
two times in a row. CSþ was always paired with UCS. After
the session, subjects were asked if they identiﬁed a stimulus
contingency and if so, asked to describe it. They rated the
experienced distress of the experimental procedure on a
scale from 1 to 10, with one indicating ‘not distressful’ and 10
denoting ‘very distressful’.
Day 2. Twenty-four hours after acquisition, the participants
returned, electrodes were attached in the same way and the
CSþ reminder was shown for 2min to facilitate memory
activation. One group then received extinction 10min
after the memory activation (the 10-min group), whereas
the other group received extinction after 6h (the 6-h group).
Extinction consisted of eight presentations of CSþ and
CS  each. Shock electrodes were applied, but no shock was
administered.
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Translational PsychiatryDay 3. Twenty-four hours after completing extinction,
participants returned for reinstatement and reacquisition.
Reinstatement consisted of four presentations of CSþ and
CS  each, with four pseudorandom shocks administered
within inter-trial intervals of about 30s. Reacquisition
consisted of four presentations of CSþ and CS  each.
CSþ was always, and CS  never paired with a shock.
Regrettably, due to a programming error, reinstatement data
were compromised and could not be retrieved for all
participants. Participants left a saliva sample for DNA
analysis, using an Oragene DNA Genotek saliva sample
container (DNA Genotek, Ottawa, Ontario, Canada).
Analyses. Stimulus-induced SCRs were calculated by
taking the maximum of the skin conductance deﬂection in
the 1.5–5.75-s interval after stimulus onset subtracted by
the immediate preceding baseline.
26 Thus, for CSþ, the
endpoint of the scoring interval coincided with UCS onset.
All SCRs were range-corrected by dividing each reaction for
every individual with that individual’s maximum deﬂection
(irrespective of stimuli and experimental phase).
27
CSþ (0.23±0.02) elicited greater responses than CS 
(0.13±0.01); t(63)¼6.25 Po1 10
 5. However, because
data from participants that do not acquire a fear memory
cannot be used to study reconsolidation processes, these
subjects were excluded from further analyses. To distinguish
those who did not acquire a conditioned reaction from those
who did, every individual’s 16 reactions to CSþ and
CS  during acquisition were ordered in pairs, and 16 delta
scores were calculated as follows: CSþ 1–CS 1,C S þ 2–
CS 2yCSþ 16–CS 16. The average delta scores were
tested against zero, using a one-tailed t-test with a statistical
cutoff of Po0.10 as the within-subject conditioning criterion.
To evaluate fear conditioning, extinction, reinstatement and
reacquistion, mean values of all CSþ and CS  trials, as well
as a delta score (CSþ minus CS ) were calculated for each
experimental phase (acquisition, extinction, reinstatement
and reacquisition) and individual, respectively. These values
were used in further analyses.
Results
Reacquisition. During reacquisition, the 6-h group (n¼15)
discriminated CSþ from CS , t(14)¼2.18, P¼0.05,
demonstrating relearning, whereas the 10-min group
(n¼18) did not, t(17)¼ 1.42, P¼0.17, reﬂecting
the absence of relearning, together resulting in a signiﬁcant
group (6h vs 10min) stimulus (CSþ vs CS ) interaction
(F(1,31)¼7.15, P¼0.01 ; see Figure 1). Moreover, the
reactions to CSþ were stronger in the 6-h group than the 10-
min group, t(31)¼1.94, P¼0.03, whereas the reactions to
CS  were not, t(31)¼0.01, P¼0.99. The two groups did not
differ in acquisition (CSþ minus CS ) t(31)¼0.23, P¼0.82,
extinction (CSþ minus CS ) t(31 )¼0.30, P¼0.76, or max
SCR t(31)¼ 0.36, P¼0.72 (6-h group mean±s.e.m.¼
0.63±0.14ms; 10-min group mean±s.e.m.¼0.69±0.11ms).
See Supplementary Table 1 for acquisition, extinction and
reacquisition data and Supplementary Table 2 for an analysis
of variance (ANOVA) summary.
To evaluate the gene group interaction, separate ANO-
VAs were performed for 5-HTTLPR and COMT, respectively,
revealing gene (s vs ll, or val/val vs met) group (6h vs
10min) interactions both for 5-HTTLPR F(1,28)¼10.77,
P¼0.003, and COMT F(1,28)¼ 10.08, P¼0.004. Follow-
up t-tests for 5-HTTLPR revealed that short-allele carriers
extinguishing outside compared with inside the reconsolida-
tion interval demonstrated stronger reacquisition,
t(21)¼4.07, Po0.001, whereas long-allele homozygotes
did not, t(7)¼ 1.58, P¼0.16. Moreover, within the 6-h
group, short-allele carriers displayed reacquistion than
along-allele homozygotes, t(12)¼2.54, P¼0.03 (see
Figure 2 top panel, Supplementary Tables 3 and 4 for data
summaries and Supplementary Table 5 for an ANOVA
summary). Similarly, follow-up t-tests regarding the val158-
met COMT polymorphism revealed that val/val homozygotes,
which extinguished outside compared with inside the recon-
solidation interval demonstrated stronger reacquisition,
t(6)¼3.03, P¼0.02, whereas met carriers did not,
t(22)¼1.00, P¼0.33. Within the 6-h group, val/val homo-
zygotes displayed stronger acquisition than the met carriers,
t(13)¼3.00, P¼0.01 (see Figure 2 bottom panel, Supple-
mentary Tables 6 and 7 for data summaries and Supplemen-
tary Table 8 for an ANOVA summary).
Regarding the 5-HTTLPR groups, short-allele carriers
(n¼23) and long-allele homozygotes (n¼9) did not differ in
acquisition, t(30)¼1.10, P¼0.28 (Supplementary Tables 3
and 4), but short-allele carriers displayed increased resis-
tance to extinction as compared with the ll homozygotes,
t(30)¼3.87, Po0.001. To explore if extinction differences
mediated the reconsolidation effect, a group (6h vs
Figure 1 Extinction during reconsolidation attenuates reacquisition of fear.
Meanrange-correctedskinconductanceresponses(SCR)tothereinforced(CSþ)
and non-reinforced (CS ) cue during reacquisition day 3. Signiﬁcant discrimination
was evident in the 6-h group that extinguished outside of the reconsolidation
interval, but not in the 10-min group that extinguished inside the reconsolidation
interval, resulting in a signiﬁcant group (6h vs 10min) stimuli (CSþ vs CS )
interaction (top panel). Error bars are s.e.m. Asterisks indicate signiﬁcant
differences. Experimental design and timeline (bottom panel).
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Translational Psychiatry10min) 5-HTTLPR (s vs ll) analysis of covariance with
extinction strength (CSþ minus CS ) as the covariate was
performed. The group 5-HTTLPR interaction effect was still
signiﬁcant, F(1,27)¼10.31, P¼0.003, suggesting that ex-
tinction is unrelated to the reconsolidation effect (Supplemen-
tary Table 9).
Regarding the val158met COMT polymorphism groups,
there was a trend towards better acquisition in the val/val
homozygotes (n¼8) as compared with the met carriers
(n¼24), t(30)¼ 1.88, P¼0.07, but no difference in extinc-
tion, t(30)¼ 0.57, P¼0.57 (Supplementary Tables 7 and 8).
To explore if the trend towards better acquisition among the
val/val homozygotes affected the reconsolidation effect, a
group (6h vs 10min) COMT (val/val vs met) analysis of
covariance with acquisition (CSþ minus CS ) as the
covariate was performed. The Group COMT interaction
wasstill signiﬁcant, F(1,27)¼9.50, P¼0.005,suggesting that
acquisition strength is unrelated to the reconsolidation effect
(Supplementary Table 10). There were not enough subjects to
perform a 5-HTTLPR COMT-polymorphism ANOVA due to
the genotype partition over subjects (Supplementary Table 11).
Reinstatement. Because of a programming error, the
reinstatement data were compromised for most subjects.
However, data retrieved from a minority of subjects revealed
a trend towards a Group effect for delta scores (CSþ minus
CS ), t(9)¼1.42, (P¼0.09 one-tailed), suggesting that
the 6-h group displayed more persistant fear memory than
the 10-min group. This effect was mediated by CSþ
responsivity, because the groups differed in response to
CSþ t(9)¼1.77, (P¼0.05 one-tailed), but not CS 
t(9)¼0.17, P¼0.87 (Supplementary Table 12). There were
too few subjects for gene effects to be evaluated.
All principal results reported for range-corrected SCRs
remainedsigniﬁcant, alsousinguntransformed data.A totalof
62 out of the 64 subjects who completed acquisition reported
contingency awareness, and as so few failed to report this, no
comparisons between contingency aware and unaware
subjects were performed. Accompanying differences in shock
strength or distress ratings (P’s40.60; see Supplementary
Table 13) were not demonstrated for any of the comparisons
reported above (6h vs 10min, s vs ll, and val/val vs met).
Participants that did acquire conditioning were not different
with aspect to genetic make-up from those that did not
(Supplementary Table 14).
Discussion
The present study demonstrates that reconsolidation disrup-
tion not only affect spontaneous recovery and reinstatement
offearaspreviouslyreported,
9but also reacquisition,and that
geneticmake-upmodulatethereconsolidationeffect.Carriers
of the short allele (but not the ll-homozygotes) of the
serotonin-transporter length polymorphism (5-HTTLPR) and
homozygotes of the val allele (but not met carriers) in the
dopamine-related COMT val158met polymorphism demon-
strated enhanced reacquisition after extinction outside, but
not inside of, the reconsolidation window. This indicates that
allelic differences modulate fear memory reconsolidation.
Carriers of the met allele and long-allele homozygotes did not
display reacquisition regardless of reconsolidation conditions,
suggesting that different allele carriers may have different
reconsolidation windows. Theoretically, it is also possible that
long-allele and met alleles are associated with enhanced
extinction retention. However, analyses evaluating the effect
of extinction as related to reacquisition does not support that
extinction differences are mediating the effect of reconsolida-
tion disruption. This pattern indicates that allelic differences
modulate fear memory reconsolidation in a complex way.
Interestingly, the polymorphisms involved are also linked to
fear conditioning,
13,14 as well as psychiatric disorders of the
affective spectrum,
28 suggesting a possible genetic link
between reconsolidation processes, fear conditioning and
psychopathology.
Figure 2 The reconsolidation effect on reacquisition is modulated by genes.
Mean differential skin conductance delta scores (CSþ minus CS ) during
reacquisition of fear after extinction inside (10min) and outside of (6h) the
reconsolidation interval in short allele carriers (s) and long-allele (ll) homozygotes of
the serotonin-transporter length 5-HTTLPR polymorphism (top panel), and the val/
val homozygotes and met carriers of the functional val158met polymorphism of the
catecholO-methyltransferase(COMT)enzyme(bottompanel).Errorbarsares.e.m.
Asterisks indicate signiﬁcant differences.
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Translational PsychiatryIn addition to the reconsolidation effect on reacquisition,
5-HTTLPR short-allele carriers demonstrated slower extinc-
tion than the long-allele homozygotes. This is consistent with
earlierstudiesreportingthatshort-allelecarriershavedelayed
extinction.
12–14 The effect of the reconsolidation manipulation
was evident in the short-allele carriers, but not in the long-
allele homozygotes. A previous cognitive behavioural treat-
ment study of the post-traumatic stress disorder demon-
strated better treatment effect in long-allele homozygotes as
comparedwiththeshort-allelecarriers.
29Thepresentﬁndings
suggests that a joint combination of retarded extinction and
enhanced renewal of fear in subjects carrying the short-allele
may be responsible for the blunted treatment response.
Possible molecular mechanisms underlying the 5-HTTLPR
effect include structural nervous-system changes during
neonatal neural development,
30 reﬂecting differences in grey
matter volume, as well as altered functional connectivity of
important structures in the emotional circuitry
31,32 and
differences in the amount of extracellular serotonin between
short-allele and long-allele carriers, possibly affecting 5HT1A-
or 5HT6-receptors that have both been tied to memory
consolidation processes.
33–35 However, studies of whether
5-HTTLPR short-allele carriers actually have more or less
extracellular serotonin in vivo have yielded mixed results.
36–38
Dopamine seems vital for the acquisition of fear conditioning.
For instance, dopamine is required in the nucleus accumbens
and the basolateral amygdala for the formation of long-term fear
memories,
19 presumably because consolidation processes
require dopamine.
21 In the present study, the inﬂuence of the
reconsolidation manipulation on reacquisition was evident for
val/val homozygotes, but not for the met carriers. Thus, val/val
homozygotes maintain and update fear memories more
effectively than met carriers supporting dopaminergic modula-
tion of reconsolidation. The val/val homozygotes have an
increased D1-receptor availability, likely resulting from the D1-
receptor upregulation caused by chronic low levels of dopa-
mine.
25,39 Both D1 and D2 receptors have been associated with
fear memory consolidation.
40,41 However, the COMT poly-
morphism doesnotseemto alter cortical or striatal dopamineD2
receptor availability in vivo,
42 suggesting that D1-receptor
activity is a putative modulator of reconsolidation.
Moreover, because amygdala reactivity has been asso-
ciated both with fear conditionability
43 and a post-traumatic
stress disorder diagnosis,
44 and as both the 5-HTTLPR
17 and
the COMT polymorphism
45–48 have been associated with
amygdala activation, there may be a link between the
amygdala reactivity and the observed reconsolidation effects.
There are some limitations to the present study. First,
reinstatement data were compromised and could only be
analysed for a minority of the participants. Second, as most of
the homozygotes of the COMT val allele appeared among the
5-HTTLPR short-allele carriers, it is hard to disentangle the
effect of one genotype from the other. However, as the
5-HTTLPR, but not the COMT, polymorphism affected
extinction, and COMT, but not 5-HTTLPR, tended to affect
acquisition, there is reason to believe that the genetic
inﬂuence from the two polymorphisms stem from different
molecular mechanisms. Finally, whether reacquisition is a
process in which a new memory is formed, or a renewal of the
original memory, cannot be determined here. Nevertheless,
our results indicate that both the lasting expression of the
original memory and renewal of fear through relearning are
affected by reconsolidation processes.
In conclusion, this study demonstrates that human memory
reconsolidation processes are inﬂuenced by serotonin and
dopamine related genes.
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